Company intelligence / Profile preview

Opalia Pharma

Kalaat El Andalous, Ariana, Tunisiaopaliafoods.com ↗

Ownership: Private
Employees: ~400
Development stage: Preclinical

Overview

Opalia Pharma is a leading Tunisian pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic medicines. It has established itself as a pioneer in Tunisia and expanded into over 25 countries across Africa and the Middle East. The company was acquired by Recordati Group in 2013, becoming its only African subsidiary. Its product portfolio covers dermatology, gastrointestinal, and respiratory therapeutic areas with most products manufactured at a cGMP-certified facility specialized in liquid and semi-solid forms.

Therapeutic areas: GastroenterologyPulmonologyDermatology
Modalities: Small molecule (generic drugs)
Industry: Biotech

Drug pipeline

1 asset

aleozen (Recordati SpA)

Unknown

Partnerships

Recordati Group (parent partnership)World Bank HQ (funding agency for some projects)Horizon Europe (2021–2027) funding agency for some projects

Beyond the preview

Go deeper on Opalia Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opalia Pharma.

Explore the full profile